Biomanufacturing in Western Switzerland 

Discover why Western Switzerland is a prime location for biomanufacturing facilities, featuring insights from industry leaders and experts.
Switzerland is home to 1,500 biotechs and about 60,000 talented scientists and leaders, making it a global hub for innovation. This video explores the advantages of Western Switzerland for biomanufacturing, featuring interviews with Massimo Nobile (Swiss Biotech Center), Adrian Zuercher (CSL Behring), Sebastien Walpen (CEIDOS), Alberto Garotti (KBI Biopharma), Juan Martin Cabaleiro (Stämm), Jonathan Dickinson (Incyte Biosciences), Sandrine Bertrand (OM Pharma), and Magali Bischof (BioAlps), as well a guest appearances by Michael Altorfer (Swiss Biotech Association), Florin Lanz (Superlab Swiss), Dawn Houghton-Bonin (Debiopharm), Pierre-Henri Belin (xcube.bio), Patrik Frei (Venture Valuation), and Andrea Chicca (Synendos Therapeutics).
Switzerland is the most innovative country in the world, and its biotech and biopharma sectors thrive thanks to a skilled workforce, excellent infrastructure, and a supportive ecosystem. Western Switzerland, with its strong political support, advanced facilities, and proximity to major players, is the ideal location for launching and growing biomanufacturing activities.
With an international network of experienced and passionate professionals, GGBa promotes Western Switzerland throughout the world.
Learn more about Biomanufacturing in Switzerland: ggba.swiss/en/key-industries/...
Find out more:
Website: www.ggba.swiss
Twitter: / ggba_invest
LinkedIn: / invest-western-switzer...

Наука